4//SEC Filing
Engle James R 4
Accession 0001104659-09-057288
CIK 0001405197other
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 2:54 PM ET
Size
8.5 KB
Accession
0001104659-09-057288
Insider Transaction Report
Form 4
Engle James R
Sr. VP, Information Technology
Transactions
- Award
Option (right to buy)
2009-09-30+5,224→ 5,224 totalExercise: $19.00Exp: 2019-09-30→ Common Stock (5,224 underlying) - Award
Common Stock
2009-09-30+2,631→ 23,871 total
Footnotes (3)
- [F1]The transaction reported in this row involves a grant by the Issuer to the Reporting Person of restricted share units representing the right to receive 2,631 shares of the Issuer's common stock that will vest in three equal annual installments beginning April 1, 2011, as detailed in a restricted share unit award agreement by and between the Issuer and the Reporting Person, dated as of September 30, 2009.
- [F2]The number of shares reported includes 8,480 shares that have not yet vested of the Issuer's common stock that were granted by the Issuer to the Reporting Person on December 6, 2006 and which will vest on March 31, 2010, subject to the Reporting Person's continuous service with the Issuer through that date, as detailed in a restricted stock award agreement by and between the Issuer and the Reporting Person, dated as of December 6, 2006.
- [F3]The transaction reported in this row involves a grant by the Issuer to the Reporting Person of options to purchase the Issuer's common stock that will vest in three equal annual installments beginning April 1, 2011, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of September 30, 2009.
Documents
Issuer
Talecris Biotherapeutics Holdings Corp.
CIK 0001405197
Entity typeother
Related Parties
1- filerCIK 0001472090
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 2:54 PM ET
- Size
- 8.5 KB